Figure 2.

Risk of atrial fibrillation in relation to NSAID use among participants in the LHID combined dataset, stratified by age, gender and various clinical characteristics. ^a Adjusted variables included: medical comorbid disorders (chronic kidney disease, myocardial infarction, sleep apnoea, hyperthyroidism, ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis, gout, coronary artery disease and valvular heart disease), and concomitant medication use (antidepressants, anticonvulsants, anxiolytics, benzodiazepines, bisphosphonates, glucocorticosteroids and hormone replacement therapy)